DIO2
Type II iodothyronine deiodinase
Also known as: IOD2_HUMAN, SELENOY, SelY, TXDI2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q92813
- Gene
- DIO2
- Ensembl
- ENSG00000211448
- Chromosome
- 14
- Canonical length
- 273 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Vesicles,Plasma membrane
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene belongs to the iodothyronine deiodinase family. It catalyzes the conversion of prohormone thyroxine (3,5,3',5'-tetraiodothyronine, T4) to the bioactive thyroid hormone (3,5,3'-triiodothyronine, T3) by outer ring 5'-deiodination. This gene is widely expressed, including in thyroid and brain. It is thought to be responsible for the 'local' production of T3, and thus important in influencing thyroid hormone action in these tissues. It has also been reported to be highly expressed in thyroids of patients with Graves disease, and in follicular adenomas. The intrathyroidal T4 to T3 conversion by this enzyme may contribute significantly to the relative increase in thyroidal T3 production in these patients. This protein is a selenoprotein containing the non-standard amino acid, selenocysteine (Sec), which is encoded by the UGA codon that normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, designated the Sec insertion sequence (SECIS) element, that is necessary for the recognition of UGA as a Sec codon, rather than as a stop signal. Unlike the other two members (DIO1 and DIO3) of this enzyme family, the mRNA for this gene contains an additional in-frame UGA codon that has been reported (in human) to function either as a Sec or a stop codon, which can result in two isoforms with one or two Sec residues; however, only the upstream Sec (conserved with the single Sec residue found at the active site in DIO1 and DIO3) was shown to be essential for enzyme activity (PMID:10403186). Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Oct 2018]
Canonical amino-acid sequenceUniProt
273 residues, UniProt reviewed canonical sequence.
>Q92813|DIO2
1 MGILSVDLLI TLQILPVFFS NCLFLALYDS VILLKHVVLL LSRSKSTRGE WRRMLTSEGL
61 RCVWKSFLLD AYKQVKLGED APNSSVVHVS STEGGDNSGN GTQEKIAEGA TCHLLDFASP
121 ERPLVVNFGS ATUPPFTSQL PAFRKLVEEF SSVADFLLVY IDEAHPSDGW AIPGDSSLSF
181 EVKKHQNQED RCAAAQQLLE RFSLPPQCRV VADRMDNNAN IAYGVAFERV CIVQRQKIAY
241 LGGKGPFSYN LQEVRHWLEK NFSKRUKKTR LAGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DIO2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0
- Highest tissue expression
- 333 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 333 nTPM
- cervix: 154 nTPM
- tongue: 66 nTPM
- esophagus: 57 nTPM
- endometrium: 38 nTPM
- salivary gland: 31 nTPM
Single-cell type
- esophageal apical cells: 2,054 nCPM
- extravillous trophoblasts: 1,050 nCPM
- breast hormone-responsive cells: 343 nCPM
- thyrotrophs: 338 nCPM
- müller glia: 219 nCPM
- lactotrophs: 189 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 45 nTPM
- midbrain: 34 nTPM
- amygdala: 31 nTPM
- pons: 30 nTPM
- hippocampal formation: 30 nTPM
- white matter: 28 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.54
- gnomAD pLI
- 0.62
- gnomAD missense Z
- 0.93
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- hormone biosynthetic process
- positive regulation of cold-induced thermogenesis
- response to lipopolysaccharide
- selenocysteine incorporation
- thyroid hormone catabolic process
- thyroid hormone generation
- thyroid hormone metabolic process
Molecular functions
- selenium binding
- thyroxine 5'-deiodinase activity
- thyroxine 5-deiodinase activity
- ubiquitin protein ligase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DIO2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DIO2 as an antibody target. Whether an autoantibody or antibody against DIO2 could matter depends on whether native DIO2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DIO2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DIO2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...